Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Haughey and Campanelli: pair of Par promotions

This article was originally published in Scrip

Executive Summary

Par Pharmaceutical, a US-based speciality pharmaceutical company, has appointed Thomas Haughey president and Paul Campanelli chief operating officer, both reporting to Patrick LePore, Par's CEO and chair. Mr Haughey has served as Par's chief administrative officer since 2008, and executive vice-president since 2006. Mr Campanelli will retain his current title of president of Par's generics division in addition to his new role, and will also assume responsibility for Strativa Pharmaceuticals, a branded division of the company.

Latest Headlines
See All
UsernamePublicRestriction

Register

SC015316

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel